Objective:The overall aim of the proposed study was to assess the feasibility and acceptability of providing short term daily oral PrEP (once daily FTC/TDF 200mg/300mg) as a potential HIV prevention tool to HIV-negative female partners of male miners in Gaza Province, Mozambique. Additional objectives were also to identify facilitators and barriers to uptake and adherence with short term once daily PrEP for HIV prevention among female partners of miners; to assess safety of PrEP use in terms of adverse events requiring discontinuation of PrEP and social harms to evaluate effect of PrEP on sexual behaviors among participants and to assess correlation between self-reported adherence, adherence measured by pill count and drug level.
Official Code: Seasonal Use of PrEP in Mozambique
Trial Sponsors: Bill & Melinda Gates Foundation, ICAP, The Employment Bureau of Africa (TEBA), WHO
February 1, 2016
May 1, 2016
Age range: 18 Years ↔ any